Waters becomes founding partner of new phenome network

Skip to Navigation


  • Published: Dec 5, 2016
  • Author: Jon Evans
  • Source: Waters
  • Suppliers: Waters Corporation
  • Channels: HPLC / Base Peak

A consortium of leading research centers from six different countries has launched the International Phenome Centre Network (IPCN). Through its commitment to harmonized metabolic phenotyping methods, the IPCN will tackle some of the most pressing global health challenges, such as autism, cancer, diabetes, dementia and obesity. Supporting the network with its chromatography and mass spectrometry technologies and expertise, Waters is a founding corporate partner of the IPCN.

Representing an advance in precision medicine research, metabolic phenotyping examines the dynamic interactions between our genes, environments, microbiomes, diets and lifestyles and their impact on disease. This research is made possible through advanced analytical science, including mass spectrometry.

Waters is a world leader in mass spectrometry technologies and methods, and will collaborate with IPCN institutions around the world to apply cutting-edge analytical and mathematical approaches to study robust and harmonized data representing the world’s diverse populations. The results could unravel the molecular underpinnings of disease and inform the development of new therapies and global public health policies.

“We are excited by the revolutionary potential of the International Phenome Centre Network to harmonize the way researchers around the world collect and assess data through metabolic phenotyping,” said Rohit Khanna, senior vice president, applied technology, at Waters. “It has been a privilege working with world-class institutions to develop and use technologies that will drive solutions to our most complex global health care challenges.”

Initiated by the MRC-NIHR National Phenome Centre (NPC) at Imperial College London in the UK, the IPCN includes more than a dozen international partners with regional, multi-institutional hubs in Australia, Canada, China, Japan, Singapore, Taiwan, the US and the UK.

Waters has long supported collaboration and the harmonization of research techniques and standards across geographies and through partnerships with industry, governments, academic centers and health systems. It has provided funding support for metabolic profiling training centers, including the Imperial International Phenome Training Centre.

“We are grateful for Waters’ collaboration in the creation of internationally harmonized centers of analytical science, focused on understanding gene-environment interactions that underpin disease risk, the comparative biology of major diseases and addressing unmet healthcare and medical needs,” said Jeremy Nicholson, director of the NPC and head of the Department of Surgery and Cancer at Imperial College London. “Waters’ expertise and international leadership in mass spectrometry and analytical science has been instrumental to the network’s success.”

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved